Stefania E. Kapsetaki

Stefania E. Kapsetaki

Auto-generated profile, based on publicly available information

Stefania E. Kapsetaki

Department of Biology, Tufts University, Medford, MA 02155, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in Cancer Discovery
Verified
Journal Article
Open access
ZCZachary Compton
Zachary Compton
WMWalker Mellon
Walker Mellon
VHValerie K. Harris
Valerie K. Harris
SRShawn Rupp
Shawn Rupp
DMDiego Mallo
Diego Mallo
ABAmy M. Boddy
Amy M. Boddy
Cancer is pervasive across multicellular species, but what explains the differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades of tetrapods (amphibians, sauropsids, and mammals), we found that neoplasia and malignancy prevalence increases with adult mass (contrary to Peto’s paradox) and somatic mutation rate but decreases with gestation time. The relationship between adult mass and malignancy prevalence was only apparent when we controlled for gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%), the black-footed penguin (<0.4%), ferrets (63%), and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and prevention of cancer. Significance: Evolution has discovered mechanisms for suppressing cancer in a wide variety of species. By analyzing veterinary necropsy records, we can identify species with exceptionally high or low cancer prevalence. Discovering the mechanisms of cancer susceptibility and resistance may help improve cancer prevention and explain cancer syndromes. See related commentary by Metzger, p. 14

15 June 2022 in Current Nutrition Reports
Verified
Journal Article
Closed access
PDF file
SKStefania E. Kapsetaki
Stefania E. Kapsetaki
GAGissel Marquez Alcaraz
Gissel Marquez Alcaraz
CMCarlo C. Maley
Carlo C. Maley
CWCorrie M. Whisner
Corrie M. Whisner
AAAthena Aktipis
Athena Aktipis

29 June 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKStefania E. Kapsetaki
Stefania E. Kapsetaki
AFAngelo Fortunato
Angelo Fortunato
ZCZachary Compton
Zachary Compton
SRShawn M. Rupp
Shawn M. Rupp
ZNZaid Nour
Zaid Nour
AAAthena Aktipis
Athena Aktipis
Chimerism is a widespread phenomenon across the tree of life. It is defined as a multicellular organism composed of cells from other genetically distinct entities. This ability to ‘tolerate’ non-self cells may be linked to susceptibility to diseases like cancer. Here we test whether chimerism is associated with cancers across obligately multicellular organisms in the tree of life. We classified 12 obligately multicellular taxa from lowest to highest chimerism levels based on the existing literature on the presence of chimerism in these species. We then tested for associations of chimerism with tumour invasiveness, neoplasia (benign or malignant) prevalence and malignancy prevalence in 11 terrestrial mammalian species. We found that taxa with higher levels of chimerism have higher tumour invasiveness, though there was no association between malignancy or neoplasia and chimerism among mammals. This suggests that there may be an important biological relationship between chimerism and susceptibility to tissue invasion by cancerous cells. Studying chimerism might help us identify mechanisms underlying invasive cancers and also could provide insights into the detection and management of emerging transmissible cancers.

1 January 2024 in Evolution, Medicine, and Public Health
Verified
Journal Article
Open access
PDF file
SKStefania E Kapsetaki
Stefania E Kapsetaki
ZCZachary T Compton
Zachary T Compton
JDJordyn Dolan
Jordyn Dolan
VHValerie Κ Harris
Valerie Κ Harris
WMWalker Mellon
Walker Mellon
Carlo MaleyCarlo Maley
Carlo Maley
Background and objectives: Cancer is a disease that affects nearly all multicellular life, including the broad and diverse taxa of Aves. While little is known about the factors that contribute to cancer risk across Aves, life history trade-offs may explain some of this variability in cancer prevalence. We predict birds with high investment in reproduction may have a higher likelihood of developing cancer. In this study, we tested whether life history traits are associated with cancer prevalence in 108 species of birds. Methodology: We obtained life history data from published databases and cancer data from 5,729 necropsies from 108 species of birds across 24 taxonomic orders from 25 different zoological facilities. We performed phylogenetically controlled regression analyses between adult body mass, lifespan, incubation length, clutch size, sexually dimorphic traits, and both neoplasia and malignancy prevalence. We also compared the neoplasia and malignancy prevalence of female and male birds. Results: Providing support for a life history trade-off between somatic maintenance and reproduction, we found a positive relationship between clutch size and cancer prevalence across Aves. There was no significant association with body mass, lifespan, incubation length, sexual dimorphism, and cancer. Conclusions and implications: Life history theory presents an important framework for understanding differences in cancer defenses across various species. These results suggest a trade-off between reproduction and somatic maintenance, where Aves with small clutch sizes get less cancer.

12 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKStefania E. Kapsetaki
Stefania E. Kapsetaki
ABAnthony J. Basile
Anthony J. Basile
ZCZachary Compton
Zachary Compton
SRShawn M. Rupp
Shawn M. Rupp
EDElizabeth G. Duke
Elizabeth G. Duke
Carlo MaleyCarlo Maley
Carlo Maley
Birds have higher plasma glucose concentrations but lower cancer prevalence than other vertebrates. However, this inverse relationship between glucose and cancer may not hold within vertebrate groups. Given that diet affects blood sugar levels, and carnivores have higher cancer risk than herbivores, we also examined whether diet correlates with plasma glucose concentrations. We collected diet, mean plasma glucose concentration, and neoplasia data for up to 273 vertebrate species from existing databases. Across vertebrates, mean plasma glucose concentration negatively correlated with cancer prevalence, but that was mostly driven by differences in mean plasma glucose concentration and cancer prevalence between birds, mammals, and reptiles. Mean plasma glucose concentration was not correlated with diet across vertebrates nor with cancer prevalence within birds, mammals, or reptiles. Primary carnivores had higher neoplasia prevalence than herbivores when controlling for domestication. A hypothetical explanation for our results may be the evolutionary loss or downregulation of genes related to insulin-mediated glucose import in bird cells. This may have led to higher mean plasma glucose concentration, lower intracellular glucose concentrations in the form of glycogen, and production of fewer reactive oxygen species and inflammatory cytokines, potentially contributing to lower neoplasia prevalence in extant birds compared to mammals and reptiles.

1 January 2024 in Evolution, Medicine, and Public Health
Verified
Journal Article
Open access
PDF file
SKStefania E Kapsetaki
Stefania E Kapsetaki
ZCZachary T Compton
Zachary T Compton
WMWalker Mellon
Walker Mellon
OVOrsolya Vincze
Orsolya Vincze
MGMathieu Giraudeau
Mathieu Giraudeau
JSJoshua D Schiffman
Joshua D Schiffman
Background and objectives: Cancer develops across nearly every species. However, cancer occurs at unexpected and widely different rates throughout the animal kingdom. The reason for this variation in cancer susceptibility remains an area of intense investigation. Cancer evolves in part through the accumulation of mutations, and therefore, we hypothesized that germline mutation rates would be associated with cancer prevalence and mortality across species.Methodology: We collected previously published data on germline mutation rate and cancer mortality data for 37 vertebrate species.Results: Germline mutation rate was positively correlated with cancer mortality (P-value = 0.0008; R2 = 0.13). Controlling for species’ average parental age, maximum longevity, adult body mass or domestication did not improve the model fit (the change (Δ) in Akaike Information Criterion (AIC) was less than 2). However, this model fit was better than a model controlling for species trophic level (ΔAIC > 2).Conclusions and implications: The increased death rate from cancer in animals with increased germline mutation rates may suggest underlying hereditary cancer predisposition syndromes similar to those diagnosed in human patients. Species with higher germline mutation rates may benefit from close monitoring for tumors due to increased genetic risk for cancer development. Early diagnoses of cancer in these species may increase their chances of overall survival, especially for threatened and endangered species.